Influence of non-steady state during isoglycemic hyperinsulinemic clamp in hypertension: A LIFE substudy

Blood Pressure

Volumn 8, Issue 4, 1999, Pages 207-213

  Olsen, Michael Hecht ^a   Andersen, Ulrik B ^a   Wachtell, Kristian ^a   Ibsen, Hans ^a   Dige Petersen, Harriet ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Hypertension; Insulin sensitivity; Isoglycemic hyperinsulinemic clamp technique; Steady state

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 0033367503     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370599439580     Document Type: Article

References (32)

1. Steele R, Marks PA. Production of glucose by the liver during hyperglycemia. Nature 1958; 182: 1444-5.
2. Andres R, Swerdloff R, Pozefsky T, Coleman D. Manual feedback technique for the control of blood glucose concentration. Automation in Analytical Chemistry 1966: 486-91.
3. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-23.
4. Bergman RN, Hope ID, Yang YJ, et al. Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev 1989; 5: 411-29.
5. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985; 6: 45-86.
6. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959-65.
7. Anderson RL, Hamman RF, Savage PJ, et al. Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study. Am J Epidemiol 1995; 142: 724-32.
8. Groop LC, Widen E, Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 1993; 36 1326-31.
9. Prager R, Wallace P, Olefsky JM. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest 1986; 78: 472-81.
10. Nolan JJ, Ludvik B, Baloga J, Reichart D, Olefsky JM. Mechanisms of the kinetic defect in insalin action in obesity and NIDDM. Diabetes 1997; 46: 994-1000.
11. Biolo G, Toigo G, Ciocchi B, Situlin R, Guarnieri G. Slower activation of insulin action in hypertension associated with obesity. J Hypertens 1998; 16: 1783-8.
12. Olsen MH, Fossum E, Hjerkinn E, et al. Vascular hypertrophy and distensibility of the carotid arteries in patients with hypertension. ICARUS, a LIFE substudy. J Am Coll Cardiol 1999; 33: 252A.
13. Dahlof B, Devereux RB, Julius S, et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Hypertension 1998; 32: 989-97
14. WHO Technical Reports Series 727. Geneva: WHO, 1985: 9.
15. DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1982; 23: 313-9.
16. Polonsky KS, Given BD, van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 1988; 81: 442-8.
17. Hother Nielsen O, Mengel A, Moller J, Rasmussen O, Schmitz O, Beck Nielsen H. Assessment of glucose turnover rates in euglycaemic clamp studies using primed-constant [3-3H]-glucose infusion and labelled or unlabelled glucose infusates. Diabet Med 1992; 9: 840-9.
18. Lillioja S, Bogardus C. Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev 1988; 4: 517-40.
19. Ader M, Bergman RN. Insulin sensitivity in the intact organism. Baillieres Clin Endocrinol Metab 1987; 1: 879-910.
20. Best JD, Taborsky GJJ, Halter JB, Porte D. Glucose disposal is not proportional to plasma glucose level in man. Diabetes 1981; 30: 847-50.
21. Baron AD, Kolterman OG, Bell J, Mandarino LJ, Olefsky JM. Rates of non-insulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest 1985; 76: 1782-8.
22. Hother Nielsen O, Beck Nielsen H. On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia 1990; 33: 603-10.
23. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39: 578-82.
24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
25. Doberne L, Greenfield MS, Schulz B, Reaven GM. Enhanced glucose utilization during prolonged glucose clamp studies. Diabetes 1981; 30: 829-35.
26. Pierdomenico SD, Lapenna D, Guglielmi MD, et al. Vascular changes in hypertensive patients with different left ventricular geometry. J Hypertens 1995; 13: 1701-6.
27. Fossum E, Høieggen A, Moan A, Rostrup M, Nordby G, Kjeldsen SE. Relationship between insulin sensitivity and maximal forearm blood flow in young men. Hypertension 1998; 32: 838-43.
28. Bergman RN. Lilly Lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989; 38: 1512-27.
29. Miles PDG, Li S, Hart M, et al. Mechanisms of insulin resistance in experimental hyperinsulinemic dogs. J Clin Invest 1998; 101: 202-11.
30. Miles PD, Levisetti M, Reichart D, Khoursheed M, Moossa AR, Olefsky JM. Kinetics of insulin action in vivo. Identification of rate-limiting steps. Diabetes 1995; 44: 947-53.
31. Shore AC, Tooke JE. Microvascular function in human essential hypertension. J Hypertens 1994; 12: 717-28.
32. Julius S, Gudbrandsson T, Jamerson KA, Tariq SS, Andersson O. The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991; 9: 983-6.